Comparison of ocular hypotensive and central visual function effects of levobunolol versus timolol gel formation in POAG

S. A. Gandolfi, Alon Harris, D. W. Evans

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Purpose: Concomitant decreases in IOP and increases in contrast sensitivity (CS) have been noted in POAG patients following topical beta blocker therapy. We evaluated two non selective beta-blocking agents for changes in IOP and CS following treatmtmt. Methods; Two groups of newly diagnosed previously untreated POAG patients were evaluated for IOP, CS, heart rate and blood pressure before and then again following 2 and 5 months of treatment. The groups were similar for age, initial level of IOP and initial level of CS. Group 1 (n= 2) was treated for two months with levobunolol (b.i.d.) and then switchsd to timolol gel formation (q.d.) for three months. Group 2 (n = 18) followed the opposite sequence. Results: Both groups demonstrated significantly reduced IOP (p <.0001) and significantly increased CS following 2 (p <.01) and 5 months (p <.01) of treatment. Group 2 exhibited an additit tnal significant decline in IOP (1I.5 ±2.4 Vs. 18.7 ±2.2 mm Hg: p = 007) and significant increase in CS (p <.05) from the 2 to 5 month treatment condition. Group 1 showed no change in IOP or CS from the 2 to 5 rionth condition. Conclusion: In PCAG patients, treatment related reductions in IOP may provide for beneficial effects in central visual function.

Original languageEnglish (US)
JournalInvestigative Ophthalmology and Visual Science
Volume38
Issue number4
StatePublished - 1997
Externally publishedYes

Fingerprint

Levobunolol
Timolol
Contrast Sensitivity
Gels
Therapeutics
Heart Rate
Blood Pressure

ASJC Scopus subject areas

  • Ophthalmology

Cite this

@article{9816b5be883c41729bce3a61dd83ecd6,
title = "Comparison of ocular hypotensive and central visual function effects of levobunolol versus timolol gel formation in POAG",
abstract = "Purpose: Concomitant decreases in IOP and increases in contrast sensitivity (CS) have been noted in POAG patients following topical beta blocker therapy. We evaluated two non selective beta-blocking agents for changes in IOP and CS following treatmtmt. Methods; Two groups of newly diagnosed previously untreated POAG patients were evaluated for IOP, CS, heart rate and blood pressure before and then again following 2 and 5 months of treatment. The groups were similar for age, initial level of IOP and initial level of CS. Group 1 (n= 2) was treated for two months with levobunolol (b.i.d.) and then switchsd to timolol gel formation (q.d.) for three months. Group 2 (n = 18) followed the opposite sequence. Results: Both groups demonstrated significantly reduced IOP (p <.0001) and significantly increased CS following 2 (p <.01) and 5 months (p <.01) of treatment. Group 2 exhibited an additit tnal significant decline in IOP (1I.5 ±2.4 Vs. 18.7 ±2.2 mm Hg: p = 007) and significant increase in CS (p <.05) from the 2 to 5 month treatment condition. Group 1 showed no change in IOP or CS from the 2 to 5 rionth condition. Conclusion: In PCAG patients, treatment related reductions in IOP may provide for beneficial effects in central visual function.",
author = "Gandolfi, {S. A.} and Alon Harris and Evans, {D. W.}",
year = "1997",
language = "English (US)",
volume = "38",
journal = "Investigative Ophthalmology and Visual Science",
issn = "0146-0404",
publisher = "Association for Research in Vision and Ophthalmology Inc.",
number = "4",

}

TY - JOUR

T1 - Comparison of ocular hypotensive and central visual function effects of levobunolol versus timolol gel formation in POAG

AU - Gandolfi, S. A.

AU - Harris, Alon

AU - Evans, D. W.

PY - 1997

Y1 - 1997

N2 - Purpose: Concomitant decreases in IOP and increases in contrast sensitivity (CS) have been noted in POAG patients following topical beta blocker therapy. We evaluated two non selective beta-blocking agents for changes in IOP and CS following treatmtmt. Methods; Two groups of newly diagnosed previously untreated POAG patients were evaluated for IOP, CS, heart rate and blood pressure before and then again following 2 and 5 months of treatment. The groups were similar for age, initial level of IOP and initial level of CS. Group 1 (n= 2) was treated for two months with levobunolol (b.i.d.) and then switchsd to timolol gel formation (q.d.) for three months. Group 2 (n = 18) followed the opposite sequence. Results: Both groups demonstrated significantly reduced IOP (p <.0001) and significantly increased CS following 2 (p <.01) and 5 months (p <.01) of treatment. Group 2 exhibited an additit tnal significant decline in IOP (1I.5 ±2.4 Vs. 18.7 ±2.2 mm Hg: p = 007) and significant increase in CS (p <.05) from the 2 to 5 month treatment condition. Group 1 showed no change in IOP or CS from the 2 to 5 rionth condition. Conclusion: In PCAG patients, treatment related reductions in IOP may provide for beneficial effects in central visual function.

AB - Purpose: Concomitant decreases in IOP and increases in contrast sensitivity (CS) have been noted in POAG patients following topical beta blocker therapy. We evaluated two non selective beta-blocking agents for changes in IOP and CS following treatmtmt. Methods; Two groups of newly diagnosed previously untreated POAG patients were evaluated for IOP, CS, heart rate and blood pressure before and then again following 2 and 5 months of treatment. The groups were similar for age, initial level of IOP and initial level of CS. Group 1 (n= 2) was treated for two months with levobunolol (b.i.d.) and then switchsd to timolol gel formation (q.d.) for three months. Group 2 (n = 18) followed the opposite sequence. Results: Both groups demonstrated significantly reduced IOP (p <.0001) and significantly increased CS following 2 (p <.01) and 5 months (p <.01) of treatment. Group 2 exhibited an additit tnal significant decline in IOP (1I.5 ±2.4 Vs. 18.7 ±2.2 mm Hg: p = 007) and significant increase in CS (p <.05) from the 2 to 5 month treatment condition. Group 1 showed no change in IOP or CS from the 2 to 5 rionth condition. Conclusion: In PCAG patients, treatment related reductions in IOP may provide for beneficial effects in central visual function.

UR - http://www.scopus.com/inward/record.url?scp=0002466990&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0002466990&partnerID=8YFLogxK

M3 - Article

VL - 38

JO - Investigative Ophthalmology and Visual Science

JF - Investigative Ophthalmology and Visual Science

SN - 0146-0404

IS - 4

ER -